VANCOUVER, British Columbia, March 03, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: MY0), an evidence-based healthcare...
VANCOUVER, British Columbia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), an evidence-based...
VANCOUVER, British Columbia, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), an evidence-based...
VANCOUVER, British Columbia, Jan. 27, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), an evidence-based...
VANCOUVER, British Columbia, Jan. 24, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), an evidence-based...
VANCOUVER, British Columbia, Jan. 17, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on...
VANCOUVER, British Columbia, Jan. 12, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTCQB: KONEF) (Frankfurt: MY0), a company focused on...
VANCOUVER, British Columbia, Jan. 10, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on...
VANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on...
VANCOUVER, British Columbia, Dec. 20, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: MY0), a company focused on...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.53 | 0.53 | 0.53 | 0 | 0 | CS |
4 | 0 | 0 | 0.53 | 0.53 | 0.53 | 0 | 0 | CS |
12 | 0 | 0 | 0.53 | 0.53 | 0.53 | 0 | 0 | CS |
26 | 0 | 0 | 0.53 | 0.53 | 0.53 | 0 | 0 | CS |
52 | 0 | 0 | 0.53 | 0.53 | 0.53 | 0 | 0 | CS |
156 | 0 | 0 | 0.53 | 0.53 | 0.53 | 0 | 0 | CS |
260 | -0.47 | -47 | 1 | 1.7 | 0.52 | 17 | 0.97451869 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales